---
schema_version: "secwatch.filing_event.v1"
accession: "0001001233-25-000011"
form_type: "8-K"
ticker: "SGMO"
cik: "0001001233"
company_name: "SANGAMO THERAPEUTICS, INC"
filed_at: "2025-09-11T23:59:59+00:00"
generated_at: "2026-05-17T06:48:40.035855+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sangamo Therapeutics CFO Prathyusha Duraibabu resigns, effective Oct 1, 2025

## Summary
- Duraibabu resigns to become senior leader at a private AI company; not due to any disagreement with Sangamo.
- She will transition to part-time employment and remain interim principal financial officer until a successor is appointed.
- Company thanks Duraibabu for contributions to strategic collaborations and investment allocations positioning Sangamo as a neurology-focused genomic medicines company.

## SEC filing metadata
- accession: 0001001233-25-000011
- form_type: 8-K
- ticker: SGMO
- cik: 0001001233
- company_name: SANGAMO THERAPEUTICS, INC
- filed_at: 2025-09-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001233/000100123325000011/0001001233-25-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001233/000100123325000011/sgmo-20250909.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001001233-25-000011
- JSON: https://secwatch.observer/filing/0001001233-25-000011.json
- Plain text: https://secwatch.observer/filing/0001001233-25-000011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.